Home / Resources / Webinar / Summer Series: Introducing Simcyp™ Discovery

Summer Series: Introducing Simcyp™ Discovery

Live webinar

Certara is pleased to announce the launch of the SimcypTM Discovery Simulator, a physiologically-based pharmacokinetic (PBPK) software developed specifically for discovery and translational scientists to increase confidence in decisions. Simcyp has been leading the scientific field of PBPK modeling for over twenty years and is used for decision-making throughout all stages of drug development and post-marketing.

While the benefits of the Simcyp Simulator are numerous and well-documented, we recognize that only a fraction of its extensive functionality is generally utilized during the initial phases of drug discovery and development. With this in mind, we are now proud to offer Simcyp Discovery. Its functionality has been tailored to address the needs of discovery and translational scientists.

If you would like to learn more about Simcyp Discovery Simulator, please register for a tour of the software and a live Q&A with our leading experts: Iain Gardner, PhD and Hannah Jones, PhD.

Key features of this new software include:


Thank you for registering!

Bio Pic IanGardner
Iain Gardner, PhD
Sr. Scientific Advisor and Head of Translational Science.
Iain leads the science team that is responsible for further developments of the population based physiologically-based PK/PD simulators to meet the needs of Simcyp Consortium members. Prior to joining Certara, he spent 12 years working in the Pharmacokinetics, Dynamics and Metabolism Department at Pfizer Global Research & Development.
Hannah Jones
Hannah Jones, PhD
Senior Vice President, Head of PBPK Consulting Services
Hannah has over 20 years experience in global pharmaceutical organizations, possessing a particularly strong background in PBPK and PKPD modelling, She has over 50 publications in PBPK/PKPD modelling and other DMPK related topics, and considerable experience influencing drug research and development programs through modelling and simulation.
Back to top